172 related articles for article (PubMed ID: 23237848)
1. Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease.
Kriegel C; Amiji MM
Clin Transl Gastroenterol; 2011 Mar; 2(3):e2. PubMed ID: 23237848
[TBL] [Abstract][Full Text] [Related]
2. Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease.
Kriegel C; Amiji M
J Control Release; 2011 Feb; 150(1):77-86. PubMed ID: 20959130
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 Gene Silencing by siRNA in Ex Vivo Human Tissue Cultures.
Piazza O; Russo I; Bochicchio S; Barba AA; Lamberti G; Zeppa P; Crescenzo VD; Carrizzo A; Vecchione C; Ciacci C
Curr Drug Deliv; 2017; 14(2):246-252. PubMed ID: 27174173
[TBL] [Abstract][Full Text] [Related]
4. Gene silencing of TNF-alpha in a murine model of acute colitis using a modified cyclodextrin delivery system.
McCarthy J; O'Neill MJ; Bourre L; Walsh D; Quinlan A; Hurley G; Ogier J; Shanahan F; Melgar S; Darcy R; O'Driscoll CM
J Control Release; 2013 May; 168(1):28-34. PubMed ID: 23500058
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and Biodistribution Analysis of Small Interference RNA for Silencing Tissue Transglutaminase-2 in Celiac Disease After Oral Administration in Mice Using Gelatin-Based Multicompartmental Delivery Systems.
Attarwala HZ; Suri K; Amiji MM
Bioelectricity; 2020 Jun; 2(2):167-174. PubMed ID: 34471844
[No Abstract] [Full Text] [Related]
6. Co-Silencing of Tissue Transglutaminase-2 and Interleukin-15 Genes in a Celiac Disease Mimetic Mouse Model Using a Nanoparticle-in-Microsphere Oral System.
Attarwala HZ; Suri K; Amiji MM
Mol Pharm; 2021 Aug; 18(8):3099-3107. PubMed ID: 34228470
[TBL] [Abstract][Full Text] [Related]
7. Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-ɑ siRNA provide a novel strategy for the experimental treatment of ulcerative colitis.
Huang Y; Guo J; Gui S
Eur J Pharm Sci; 2018 Dec; 125():232-243. PubMed ID: 30315858
[TBL] [Abstract][Full Text] [Related]
8. Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target.
Peer D; Park EJ; Morishita Y; Carman CV; Shimaoka M
Science; 2008 Feb; 319(5863):627-30. PubMed ID: 18239128
[TBL] [Abstract][Full Text] [Related]
9. Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease.
Bhavsar MD; Amiji MM
Gene Ther; 2008 Sep; 15(17):1200-9. PubMed ID: 18418416
[TBL] [Abstract][Full Text] [Related]
10. Oral TNF-α siRNA delivery via milk-derived exosomes for effective treatment of inflammatory bowel disease.
Han G; Kim H; Jang H; Kim ES; Kim SH; Yang Y
Bioact Mater; 2024 Apr; 34():138-149. PubMed ID: 38223538
[TBL] [Abstract][Full Text] [Related]
11. Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice.
Naito Y; Takagi T; Handa O; Ishikawa T; Nakagawa S; Yamaguchi T; Yoshida N; Minami M; Kita M; Imanishi J; Yoshikawa T
J Gastroenterol Hepatol; 2003 May; 18(5):560-9. PubMed ID: 12702049
[TBL] [Abstract][Full Text] [Related]
12. siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn's Disease.
Russo I; Carrizzo A; Bochicchio S; Piazza O; Lamberti G; Barba AA; Vecchione C; Zeppa P; Iovino P; Bucci C; Santonicola A; Ciacci C
Transl Med UniSa; 2017 Jul; 17():25-33. PubMed ID: 30083520
[TBL] [Abstract][Full Text] [Related]
13. siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn's Disease.
Russo I; Carrizzo A; Bochicchio S; Piazza O; Lamberti G; Barba AA; Vecchione C; Zeppa P; Iovino P; Bucci C; Santonicola A; Ciacci C
Transl Med UniSa; 2017 Jul; 17():22-30. PubMed ID: 30050877
[TBL] [Abstract][Full Text] [Related]
14. Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles.
Lokras A; Thakur A; Wadhwa A; Thanki K; Franzyk H; Foged C
Front Bioeng Biotechnol; 2020; 8():601155. PubMed ID: 33520957
[TBL] [Abstract][Full Text] [Related]
15. alpha-Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Ishikawa T; Handa O; Matsumoto N; Yagi N; Matsuyama K; Yoshida N; Yoshikawa T; Kotake Y
Antioxid Redox Signal; 2002 Feb; 4(1):195-206. PubMed ID: 11970853
[TBL] [Abstract][Full Text] [Related]
16. Cosilencing Intestinal Transglutaminase-2 and Interleukin-15 Using Gelatin-Based Nanoparticles in an in Vitro Model of Celiac Disease.
Attarwala H; Clausen V; Chaturvedi P; Amiji MM
Mol Pharm; 2017 Sep; 14(9):3036-3044. PubMed ID: 28737923
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages.
He C; Yin L; Tang C; Yin C
Biomaterials; 2013 Apr; 34(11):2843-54. PubMed ID: 23347838
[TBL] [Abstract][Full Text] [Related]
18. Colonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivo.
Frede A; Neuhaus B; Klopfleisch R; Walker C; Buer J; Müller W; Epple M; Westendorf AM
J Control Release; 2016 Jan; 222():86-96. PubMed ID: 26699423
[TBL] [Abstract][Full Text] [Related]
19. Canine adipose tissue-derived mesenchymal stem cells pre-treated with TNF-alpha enhance immunomodulatory effects in inflammatory bowel disease in mice.
Song WJ; Li Q; Ryu MO; Nam A; An JH; Jung YC; Ahn JO; Youn HY
Res Vet Sci; 2019 Aug; 125():176-184. PubMed ID: 31247473
[TBL] [Abstract][Full Text] [Related]
20. γ-Glutamyl cysteine and γ-glutamyl valine inhibit TNF-α signaling in intestinal epithelial cells and reduce inflammation in a mouse model of colitis via allosteric activation of the calcium-sensing receptor.
Zhang H; Kovacs-Nolan J; Kodera T; Eto Y; Mine Y
Biochim Biophys Acta; 2015 May; 1852(5):792-804. PubMed ID: 25558818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
